Clinical Trials Browser

Phase 1 × Interventional × Pancreatic Ductal Adenocarcinoma (PDAC) × Clear all

NCT06182072 2025-10-01

ProAgio in Pancreatic Ductal Adenocarcinoma (PDAC)

Phase 1 Recruiting

Gastrointestinal

Pancreatic Ductal Adenocarcinoma (PDAC)

NCT02782182 2019-03-19

Perioperative FOLFIRINOX for Patients With Resectable Pancreatic Adenocarcinoma: A Pilot Study

Phase 1 Terminated

Gastrointestinal

Pancreatic Ductal Adenocarcinoma (PDAC)